Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
21.12
-0.21 (-0.98%)
At close: Aug 1, 2025, 4:00 PM
21.01
-0.11 (-0.52%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Company Description

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy.

The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets.

Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals logo
CountryUnited States
Founded2002
IPO DateNov 8, 2006
IndustryBiotechnology
SectorHealthcare
Employees181
CEORichard John Daly

Contact Details

Address:
355 Alhambra Circle, Suite 801
Coral Gables, Florida 33134
United States
Phone305 420 3200
Websitecatalystpharma.com

Stock Details

Ticker SymbolCPRX
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001369568
CUSIP Number14888U101
ISIN NumberUS14888U1016
SIC Code2834

Key Executives

NamePosition
Richard John Daly M.B.A.President, Chief Executive Officer and Director
Michael W. Kalb CPAExecutive Vice President, Treasurer and Chief Financial Officer
Dr. Steven R. Miller Ph.D.Executive Vice President, Chief Operating Officer and Chief Scientific Officer
Jeffrey Del CarmenExecutive Vice President and Chief Commercial Officer
Dr. Preethi Sundaram Ph.D.Chief Strategy Officer
Mary ColemanVice President and Head of Investor Relations
Brian Elsbernd J.D.Chief Compliance Officer and Chief Legal Officer
Gregg RussoChief Human Resources Officer
Dr. Stanley Iyadurai M.D., Ph.D.Senior Vice President of Medical Affairs and Drug Discovery
Dr. William T. Andrews FACP, M.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Jun 11, 2025144Filing
Jun 10, 2025144Filing
Jun 6, 2025144Filing
Jun 2, 20258-KCurrent Report
Jun 2, 2025144Filing
May 30, 2025144Filing
May 30, 2025144Filing
May 23, 20258-KCurrent Report
May 14, 2025144Filing
May 13, 2025144Filing